Praxis Precision Medicines (PRAX) Operating Margin

Praxis Precision Medicines, Inc. (PRAX) - corporate logo

Praxis Precision Medicines demonstrates resilience to macroeconomic crises, rendering the asset defensive. The operating margin confirms this trend, with the metric reaching the level of 0.00. Success is based on the therapy of genetic CNS pathologies and epilepsy. Global scaling is driven by the ownership of unique patents, which enable the distribution of innovative drugs worldwide.

praxismedicines.com (PRAX): Profitability of Operations from 07/04/2022 to 11/20/2026

Metric breakdowns and analytics for praxismedicines.com (PRAX)

- share price and consensus valuation forecast:
General company analysis:Praxis Medicines
Core merchandise of Praxis Precision Medicines

Operating margin measures cost management efficiency, determining the share of profit from core operations before accounting for financial obligations and taxes. Regular monitoring of operating profitability allows an investor to promptly detect a decline in returns from production processes. The metric is calculated as the ratio of operating profit to revenue, reflecting the internal viability of the model. For Praxis Precision Medicines (PRAX), this figure remains negative due to the absence of commercial products. The company's current financial health is sustained by raised capital, which supports the development of epilepsy drugs.

Competitor analysis for Praxis Precision Medicines

Operating Sales Margin BIIB|NBIX: Operating Profit Rate|Operating Profitability Regencell Bioscience Ltd (RGC)|Operating Margin axsome.com (AXSM)|Operating Margin ACAD (acadia-pharm.com)|XENE - Operating Sales Margin|vikingtherapeutics.com - Operating Margin|Supernus Pharma (SUPN) - Operating Sales Margin|CPRX: Operating Margin|Denali Therapeutics Inc. (DNLI) - Operating Margin|Operating Profitability Harmony Pharma|Operating Profitability BHVN|Operating Sales Margin AMLX (Amylyx Pharmaceuticals, Inc.)|Operating Sales Margin Trevi Corp TRVI|Operating Margin AVXL (anavex.com)|CBLL: Return on Sales by Operating Profit|PRTA - Operating Profitability|ALEC - Operating Margin|Annexon Inc. (ANNX) - Operating Profitability|Operating Sales Margin Omeros Corp|Operating Sales Margin NGNE|ACIU: Operating Profit Rate|Operating Sales Margin VYGR (Voyager Corp)|Operating Sales Margin Neumora NMRA|Operating Profitability Scilex Holding Company, Inc. SCLX|Operating Profitability Margin Tevogen Bio Inc.|ACOG - Operating Profitability|Operating Profitability Margin Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Operating Sales Margin|Cassava Sciences Inc (SAVA) - Operating Margin|Operating Sales Margin ASRT|Operating Margin coyatherapeutics.com|Operating Margin VTGN|Ovid Therapeutics - Return on Sales by Operating Profit|Operating Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Operating Sales Margin|ATHE - Operating Profitability|Profitability of Operations clene.com CLNN|PEPG: Operating Margin|Return on Sales by Operating Profit JUNS|RLMD (Relmada Corp) - Operating Margin|Annovis Bio Inc (ANVS) - Profitability of Operations|Operating Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operating Profit Rate|Operating Profitability Klotho Neurosciences KLTO|NRSN: Return on Sales by Operating Profit|RVPH: Operating Sales Margin|MTVA: Operating Profitability|NRXS (NeurAxis Inc) - Operating Sales Margin|Operating Sales Margin Helius Medical Technologies, Inc.|Operating Profitability Passage Bio Inc.|Operating Return on Sales bionomics.com.au NEUP|Operating Margin NERV|Operating Margin Athira Pharma Inc (ATHA)|Operating Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Return on Sales by Operating Profit|CYCN - Operating Profitability|Operating Return on Sales Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Operating Sales Margin|Operating Profitability Margin Cortigent, Inc. CRGT|Operating Profitability Avenue Therapeutics, Inc.|Operating Sales Margin BrainStorm Cell Therapeutics Inc. (BCLI)|Operating Profitability Cara Therapeutics, Inc (CARA)|Operating Profitability CHRO (Chromocell Therapeutics Corp.)|Operating Margin ELYM (eliemtx.com)|intracellulartherapies.com - Operating Profitability|LBPH: Operating Sales Margin|Operating Profit Rate MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Operating Sales Margin|Operating Sales Margin NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operating Margin|Neurotrope - Operating Profit Margin|Operating Margin TRVN|Profitability of Operations Vigil Neuroscience, Inc.|Operating Profitability Anew Medical, Inc. WENA|CERE - Operating Sales Margin